VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
Stopped Sponsor decision
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG: VIC-1911
- DRUG: sotorasib
Sponsor
Vitrac Therapeutics, LLC
Collaborators